Search Results

• • 12 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Monkeypox encephalitis with transverse myelitis in a female patient.

  Authors:Joby Cole, Saher Choudry, Saminderjit Kular, Thomas Payne, Suha Akili, Helen Callaby, et al.From:The Lancet Infectious Diseases (Vol. 23, Issue 3) Peer-Reviewed

  Mar. 2023288 words Brief article

   Abstract Only

• Hidden sources of bias in diagnostic studies: the example of visceral leishmaniasis in east Africa.

  Authors:Johan van Griensven, Ermias Diro, and Cedric P YansouniFrom:The Lancet Infectious Diseases (Vol. 23, Issue 3) Peer-Reviewed

  Mar. 2023224 words Brief article

   Abstract Only

• Necrotising soft-tissue infections.

  Authors:Camille Hua, Tomas Urbina, Romain Bosc, Tom Parks, Shiranee Sriskandan, Nicolas de Prost, et al.From:The Lancet Infectious Diseases (Vol. 23, Issue 3) Peer-Reviewed

  Mar. 2023339 words Article

   Abstract Only

• Safety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trial.

  Authors:Daniela Manno, Agnes Bangura, Frank Baiden, Abu Bakarr Kamara, Philip Ayieko, Joseph Kallon, et al.From:The Lancet Infectious Diseases (Vol. 23, Issue 3) Peer-Reviewed

  Mar. 2023703 words Report

   Abstract Only

• Immunological signature in human cases of monkeypox infection in 2022 outbreak: an observational study.

  Authors:Chiara Agrati, Andrea Cossarizza, Valentina Mazzotta, Germana Grassi, Rita Casetti, Sara De Biasi, et al.From:The Lancet Infectious Diseases (Vol. 23, Issue 3) Peer-Reviewed

  Mar. 2023740 words Report

   Abstract Only

• Treatment of erythema migrans with doxycycline for 7 days versus 14 days in Slovenia: a randomised open-label non-inferiority trial.

  Authors:Dasa Stupica, Stefan Collinet-Adler, Rok Blagus, Anja Gomiscek, Tjasa Cerar Kisek, Eva Ruzic-Sabljic, et al.From:The Lancet Infectious Diseases (Vol. 23, Issue 3) Peer-Reviewed

  Mar. 2023572 words Article

   Abstract Only

• Efficacy and safety of moxidectin and albendazole compared with ivermectin and albendazole coadministration in adolescents infected with Trichuris trichiura in Tanzania: an open-label, non-inferiority, randomised, controlled, phase 2/3 trial.

  Authors:Sophie Welsche, Emmanuel C Mrimi, Jan Hattendorf, Eveline Hürlimann, Said M Ali, and Jennifer KeiserFrom:The Lancet Infectious Diseases (Vol. 23, Issue 3) Peer-Reviewed

  Mar. 2023528 words Article

   Abstract Only

• Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine--pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance study.

  Authors:Khalid B Beshir, Julian Muwanguzi, Johanna Nader, Raoul Mansukhani, Aliou Traore, Kadidja Gamougam, et al.From:The Lancet Infectious Diseases (Vol. 23, Issue 3) Peer-Reviewed

  Mar. 2023690 words Article

   Abstract Only

• Unveiling the incidences and trends of the neglected zoonosis cystic echinococcosis in Europe: a systematic review from the MEmE project.

  Authors:Adriano Casulli, Bernadette Abela-Ridder, Daniele Petrone, Massimo Fabiani, Branko Bobic, David Carmena, et al.From:The Lancet Infectious Diseases (Vol. 23, Issue 3) Peer-Reviewed

  Mar. 2023980 words Article

   Abstract Only

• Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial.

  Authors:Marcia M L Kho, A Lianne Messchendorp, Sophie C Frölke, Celine Imhof, Vera JCH Koomen, S Reshwan K Malahe, et al.From:The Lancet Infectious Diseases (Vol. 23, Issue 3) Peer-Reviewed

  Mar. 2023870 words Article

   Abstract Only

• Effect of systematic tuberculosis detection on mortality in young children with severe pneumonia in countries with high incidence of tuberculosis: a stepped-wedge cluster-randomised trial.

  Authors:Olivier Marcy, Eric Wobudeya, Hélène Font, Aurélia Vessière, Chishala Chabala, Celso Khosa, et al.From:The Lancet Infectious Diseases (Vol. 23, Issue 3) Peer-Reviewed

  Mar. 20231,596 words Report

   Abstract Only

• Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b--2a trial.

  Authors:Shabir A Madhi, Gaurav Kwatra, Simone I Richardson, Anthonet L Koen, Vicky Baillie, Clare L Cutland, et al.From:The Lancet Infectious Diseases (Vol. 23, Issue 3) Peer-Reviewed

  Mar. 2023847 words Report

   Abstract Only